| # | Drug | Count |
|---|---|---|
| 0 | DARUNAVIR | 4 |
| 1 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 4 |
| 2 | RITONAVIR | 4 |
| 3 | VALACYCLOVIR | 4 |
| 4 | VALACYCLOVIR HYDROCHLORIDE | 4 |
| 5 | CALCIUM | 2 |
| 6 | LAMIVUDINE | 2 |
| 7 | LAMIVUDINE ORAL | 2 |
| 8 | DORAVIRINE | 1 |
| 9 | ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DORAVIRINE | 1 | 0.0013 |
| 1 | DARUNAVIR | 4 | 0.0003 |
| 2 | ETRAVIRINE | 1 | 0.0002 |
| 3 | RILPIVIRINE | 1 | 0.0001 |
| 4 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 1 | 0.0001 |
| 5 | ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE | 1 | 0.0001 |
| 6 | ZIDOVUDINE | 1 | 0.0001 |
| 7 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 4 | 0.0001 |
| 8 | LAMIVUDINE | 2 | 0.0001 |
| 9 | VALACYCLOVIR HYDROCHLORIDE | 4 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Protease Inhibitor [EPC] | 4 | 0.0001 |
| 1 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0001 |
| 2 | Cytochrome P450 3A Inhibitor [EPC] | 5 | 0.0001 |
| 3 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 9 | 0.0001 |
| 4 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0000 |
| 5 | Calcium [EPC] | 2 | 0.0000 |